Does Glutamine Promote Benefits for Patients With Diabetes Mellitus Scheduled for Cardiac Surgery?

Heart Lung and Circulation

Volumn 22, Issue 5, 2013, Pages 360-365

  Lomivorotov, Vladimir V ^a   Efremov, Sergey M ^a   Shmirev, Vladimir A ^a   Ponomarev, Dmitry N ^a   Svyatchenko, Alexandr V ^a   Deryagin, Mihail N ^a   Lomivorotov, Vladimir N ^a   Karaskov, Alexander M ^a  

^a MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

Author keywords

Cardiac protection; Cardiopulmonary bypass; Diabetes mellitus; Glutamine; Insulin resistance

Indexed keywords

ALANYLGLUTAMINE; FATTY ACID; GLUCOSE; PLACEBO; TRIACYLGLYCEROL; TROPONIN I;

ADULT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART HEMODYNAMICS; HEART PROTECTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; THERMODILUTION; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BLOOD GLUCOSE; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIPEPTIDES; DOUBLE-BLIND METHOD; FATTY ACIDS; FEMALE; GLUTAMINE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; TRIGLYCERIDES; TROPONIN I;

EID: 84876800203     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2012.11.011     Document Type: Article

References (24)

1. Murphy G.J., Angelini G.D. Side effects of cardiopulmonary bypass: what is the reality?. J Card Surg 2004, 19:481-488.
2. Thorell A., Nygren J., Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 1999, 2:69-78.
3. Sato H., Carvalho G., Sato T., Lattermann R., Matsukawa T., Schricker T. The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab 2010, 95:4338-4344.
4. Wallace T.M., Matthews D.R. The assessment of insulin resistance in man. Diabet Med 2002, 19:527-534.
5. Schricker T., Lattermann R., Schreiber M., Geisser W., Georgieff M., Radermacher P. The hyperglycaemic response to surgery: pathophysiology, clinical implications and modification by the anaesthetic technique. Clin Intensive Care 1998, 9:118-128.
6. Saltiel R.A. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001, 104:517-529.
7. Ginsberg H.N. Insulin resistance and cardiovascular disease. J Clin Invest 2000, 106:453-458.
8. Lomivorotov V.V., Efremov S.M., Shmirev V.A., Ponomarev D.N., Lomivorotov V.N., Karaskov A.M. Glutamine is cardioprotective in patients with ischemic heart disease following cardiopulmonary bypass. Heart Surg Forum 2011, 14:E384-E388.
9. Sufit A., Weitzel L.B., Hamiel C., Queensland K., Dauber I., Rooyackers O., et al. Pharmacologically dosed oral glutamine reduces myocardial injury in patients undergoing cardiac surgery: a randomized pilot feasibility trial. JPEN J Parenter Enteral Nutr 2012, 36:556-561.
10. Bakalar B., Duska F., Pachl J., Fric M., Otahal M., Pazout M., et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 2006, 34:381-386.
11. Dechelotte P., Hasselmann M., Cynober L., Allaouchiche B., Coëffier M., Hecketsweiler B., et al. l-Alanyl-l-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006, 34:598-604.
12. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
13. Furnary A.P., Zerr K.J., Grunkemeier G.L., Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67:352-360.
14. Schoonjans F., Zalata A., Depuydt C.E., Comhaire F.H. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995, 48:257-262.
15. Delogu G., Signore M., Mechelli A., Famularo G. Heat shock proteins and their role in heart injury. Curr Opin Crit Care 2002, 8:411-416.
16. Wischmeyer P.E. Glutamine: the first clinically relevant pharmacological regulator of heat shock protein expression?. Curr Opin Clin Nutr Metab Care 2006, 9:201-206.
17. Nakhjavani M., Morteza A., Khajeali L., Esteghamati A., Khalilzadeh O., Asgarani F., et al. Increased serum HSP70 levels are associated with the duration of diabetes. Cell Stress Chaperones 2010, 15:959-964.
18. Ugurlucan M., Erer D., Karatepe O., Ziyade S., Haholu A., Gungor Ugurlucan F., et al. Glutamine enhances the heat shock protein 70 expression as a cardioprotective mechanism in left heart tissues in the presence of diabetes mellitus. Expert Opin Ther Targets 2010, 14:1143-1156.
19. Dungan K.M., Braithwaite S.S., Preiser J.C. Stress hyperglycaemia. Lancet 2009, 373:1798-1807.
20. Ljungqvist O., Jonathan E. Rhoads lecture 2011: insulin resistance and enhanced recovery after surgery. JPEN J Parenter Enteral Nutr 2012, 36:389-398.
21. Doenst T., Wijeysundera D., Karkouti K., Zechner C., Maganti M., Rao V., et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005, 130:1144-1150.
22. Bakalar B., Duska F., Pachl J., Fric M., Otahal M., Pazout J., et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 2006, 34:381-386.
23. Roth E. Nonnutritive effects of glutamine. J Nutr 2008, 138:2025S-2031S.
24. Lazar H.L., McDonnell M., Chipkin S.R., Furnary A.P., Engelman R.M., Sadhu A.R., et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009, 87:663-669.